A comparison of immobilisation quality and cardiorespiratory effects of etorphine-azaperone versus etorphine-midazolam combinations in blesbok

dc.contributor.authorLaubscher, Liesel L.
dc.contributor.authorMeyer, Leith Carl Rodney
dc.contributor.authorLaurence, M.
dc.contributor.authorRaath, J.P.
dc.contributor.authorPfitzer, S.
dc.date.accessioned2023-08-24T05:47:13Z
dc.date.available2023-08-24T05:47:13Z
dc.date.issued2022
dc.description.abstractThe study compared immobilisation of blesbok (Damaliscus pygargus phillipsi) with etorphine and azaperone vs etorphine and midazolam. Twelve female blesbok, weighing 59.4 ± 2.8 kg, were used. Each animal randomly received Treatment 1 (T1) (etorphine, 0.07 ± 0.003 mg/kg + azaperone, 0.36 ± 0.02 mg/kg) and Treatment 2 (T2) (etorphine, 0.07 ± 0.003 mg/kg + midazolam, 0.20 ± 0.01 mg/kg) with a one-week washout period between treatments. Induction times were recorded followed by physiological monitoring for 45 minutes of immobilisation. Immobilisation was reversed with naltrexone (20 mg per mg etorphine). Recovery times were also recorded. Induction, immobilisation and recovery were scored with subjective measures. Inductions and recoveries did not differ between combinations, but the quality of immobilisation was significantly better with T1. Rectal temperature and blood pressure were significantly lower during T1. Both treatments resulted in severe hypoxaemia and impaired gas exchange, although overall hypoxaemia was more pronounced for T1. Animals treated with T2, however, exhibited a deterioration in respiration as the monitoring period progressed, possibly as a result of impaired ventilatory muscle function due to the effects of midazolam. Both combinations are suitable for adequate immobilisation of blesbok and should be selected based on the specific capture situation. Supplementation with oxygen is highly recommended.en_US
dc.description.departmentCentre for Veterinary Wildlife Studiesen_US
dc.description.departmentParaclinical Sciencesen_US
dc.description.librarianam2023en_US
dc.description.sponsorshipWildlife Pharmaceuticals (Pty) Ltd. and Murdoch University.en_US
dc.description.urihttp://www.jsava.co.zaen_US
dc.identifier.citationLaubscher, L.L., Meyer, L.C.R., Laurence, M. et al. 2022, 'A comparison of immobilisation quality and cardiorespiratory effects of etorphine-azaperone versus etorphine-midazolam combinations in blesbok', Journal of the South African Veterinary Association, vol. 93, no. 1, pp. 1-9, doi : 10.36303/JSAVA.2022.93.1.491.en_US
dc.identifier.issn1019-9128 (print)
dc.identifier.issn2224-9435 (online)
dc.identifier.other10.36303/JSAVA.2022.93.1.491
dc.identifier.urihttp://hdl.handle.net/2263/92021
dc.language.isoenen_US
dc.publisherMedPharm Publicationsen_US
dc.rightsOpen Access article distributed under the terms of the Creative Commons License [CC BY-NC 3.0].en_US
dc.subjectAzaperoneen_US
dc.subjectMidazolamen_US
dc.subjectCardiorespiratory functionen_US
dc.subjectChemical immobilisationen_US
dc.subjectEtorphineen_US
dc.subjectBlesbok (Damaliscus pygargus phillipsi)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleA comparison of immobilisation quality and cardiorespiratory effects of etorphine-azaperone versus etorphine-midazolam combinations in blesboken_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Laubscher_Comparison_2022.pdf
Size:
298.45 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: